About Macrocure Ltd
MacroCure Ltd. is a biotechnology company. The Company is focused on developing, manufacturing and commercializing cell therapy products to address unmet needs for the treatment of chronic wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Its product candidate, CureXcell, is a combination of living human white blood cells that have been activated to facilitate the healing process and stimulate wound closure. CureXcell is in Phase III. Its CureXcell addresses each phase of healing in the impaired wound, including the production of growth factors and other biochemical factors involved in fibroblast activation, cell migration and extracellular matrix production, stimulating the body's natural healing process. Its delivery method of direct superficial injection into the chronic wound allows the precise delivery of the cells into the defective wound tissue where they can be effective.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: MCUR
Companies Related to Macrocure Ltd:
- Previous Close: $1.51
- 50 Day Moving Average: $1.50
- 200 Day Moving Average: $1.54
- 52-Week Range: $0.75 - $3.20
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -4.72
- P/E Growth: 0.00
- Market Cap: $N/A
- Beta: 0.62
Earnings History for Macrocure Ltd (NASDAQ:MCUR)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/16/2016|| || || || || || || || |
Earnings Estimates for Macrocure Ltd (NASDAQ:MCUR)
Current Year EPS Consensus Estimate: $-0.32 EPS
Next Year EPS Consensus Estimate: $-0.32 EPS
Dividend History for Macrocure Ltd (NASDAQ:MCUR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Macrocure Ltd (NASDAQ:MCUR)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for Macrocure Ltd (NASDAQ:MCUR)
What is Macrocure Ltd's stock symbol?
Macrocure Ltd trades on the NASDAQ under the ticker symbol "MCUR."
Where is Macrocure Ltd's stock going? Where will Macrocure Ltd's stock price be in 2017?
1 brokerages have issued 1-year price objectives for Macrocure Ltd's stock. Their forecasts range from $1.00 to $1.00. On average, they anticipate Macrocure Ltd's stock price to reach $1.00 in the next year.
When will Macrocure Ltd announce their earnings?
Macrocure Ltd is scheduled to release their next quarterly earnings announcement on Wednesday, March, 16th 2016.
Who owns Macrocure Ltd stock?
Macrocure Ltd's stock is owned by many different of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.00%).
Who bought Macrocure Ltd stock? Who is buying Macrocure Ltd stock?
Macrocure Ltd's stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
How do I buy Macrocure Ltd stock?
Shares of Macrocure Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Macrocure Ltd stock cost?
One share of Macrocure Ltd stock can currently be purchased for approximately $1.51.
Macrocure Ltd (NASDAQ:MCUR) Chart for Tuesday, February, 21, 2017
Institutional Ownership ChartEarnings History ChartDividend History Chart